Viveve Medical Inc (NASDAQ:VIVE) shares fell 7.7% during mid-day trading on Monday . The company traded as low as $0.11 and last traded at $0.12, 7,276,426 shares were traded during trading. An increase of 390% from the average session volume of 1,485,001 shares. The stock had previously closed at $0.13.
A number of research firms recently issued reports on VIVE. Maxim Group reissued a “hold” rating on shares of Viveve Medical in a research report on Friday, August 9th. Stifel Nicolaus downgraded shares of Viveve Medical from a “buy” rating to a “hold” rating and dropped their target price for the stock from $3.00 to $1.00 in a research report on Monday, July 22nd. Mizuho downgraded shares of Viveve Medical from a “buy” rating to an “underperform” rating and dropped their target price for the stock from $4.00 to $0.20 in a research report on Tuesday, July 23rd. Raymond James downgraded shares of Viveve Medical from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 23rd. Finally, LADENBURG THALM/SH SH downgraded shares of Viveve Medical from a “buy” rating to a “neutral” rating in a research report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $2.24.
The stock has a market cap of $5.99 million, a PE ratio of -0.08 and a beta of -0.21. The stock has a fifty day simple moving average of $0.26 and a two-hundred day simple moving average of $0.61. The company has a debt-to-equity ratio of 6.21, a quick ratio of 3.43 and a current ratio of 2.98.
Viveve Medical Company Profile (NASDAQ:VIVE)
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.
Recommended Story: Why is a lock-up period needed for an IPO?
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.